TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07594860: Assessment Of Gut Microbiome Changes During Antibiotic Treatment With Probiotic, Postbiotic Or Placebo: A Randomized, Triple-blind, Placebo-controlled Pilot Study.

Sponsor: The Archer-Daniels-Midland Company · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 126 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT07594860 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07594860 Rescue Dossier →